共 50 条
- [1] A phase 1b study evaluating the safety and pharmacokinetics of regorafenib in combination with cetuximab in patients with advanced solid tumorsINTERNATIONAL JOURNAL OF CANCER, 2019, 145 (09) : 2450 - 2458Weekes, ColinLockhart, A. CraigLee, James J.Sturm, IsridCleton, AdriaanHuang, FunanLenz, Heinz-Josef
- [2] A phase 1b study evaluating the safety and pharmacokinetics (PK) of regorafenib (REG) in combination with cetuximab (CTX) in patients with advanced solid tumorsANNALS OF ONCOLOGY, 2017, 28Weekes, C.Lockhart, A. C.Lenz, H-J.Lee, J. J.Cleton, A.Huang, F.Sturm, I.
- [3] A phase 1 study evaluating the pharmacokinetics (PK), safety, and efficacy of regorafenib (REG) in Chinese patients with advanced, refractory solid tumorsANNALS OF ONCOLOGY, 2016, 27Cao, J.Ji, D.Shen, W.Wang, Q.Liu, Y.Lu, D.Sturm, I.Huang, F.Cleton, A.
- [4] A phase 1 study evaluating the pharmacokinetics (PK) and safety of regorafenib (REG) in patients with advanced solid tumors with severe renal impairment (SRI)ANNALS OF ONCOLOGY, 2016, 27Renouf, D. J.Hirte, H. W.O'Bryant, C. L.Trnkova, Z. J.Cleton, A.Huang, F.Mueller, U.Ayoub, J-P.Lockhart, A. C.Quinn, D. I.Dy, G. K.Sawyer, M. B.
- [5] Regorafenib in Japanese patients with solid tumors: phase I study of safety, efficacy, and pharmacokineticsINVESTIGATIONAL NEW DRUGS, 2014, 32 (01) : 104 - 112Sunakawa, YuFuruse, JunjiOkusaka, TakujiIkeda, MasafumiNagashima, FumioUeno, HidekiMitsunaga, ShuichiHashizume, KenseiIto, YuichiroSasaki, Yasutsuna
- [6] Regorafenib in Japanese patients with solid tumors: phase I study of safety, efficacy, and pharmacokineticsInvestigational New Drugs, 2014, 32 : 104 - 112Yu SunakawaJunji FuruseTakuji OkusakaMasafumi IkedaFumio NagashimaHideki UenoShuichi MitsunagaKensei HashizumeYuichiro ItoYasutsuna Sasaki
- [7] Phase 1 Study of Combination Treatment with PTK 787/ZK 222584 and Cetuximab for Patients with Advanced Solid Tumors: Safety, Pharmacokinetics, Pharmacodynamics AnalysisNEOPLASIA, 2010, 12 (02): : 206 - 213Langenberg, Marlies H. G.Witteveen, Petronella O.Lankheet, Nienke A. G.Roodhart, Jeanine M. L.Rosing, Hildevan den Heuvel, Ingeborg J. G. M.Beijnen, Jos H.Voest, Emile E.
- [8] Erratum to: Regorafenib in Japanese patients with solid tumors: phase I study of safety, efficacy, and pharmacokineticsInvestigational New Drugs, 2014, 32 : 388 - 388Yu SunakawaJunji FuruseTakuji OkusakaMasafumi IkedaFumio NagashimaHideki UenoShuichi MitsunagaKensei HashizumeYuichiro ItoYasutsuna Sasaki
- [9] Phase I study of temsirolimus in combination with cetuximab in patients with advanced solid tumors.JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)Hollebecque, AntoineBahleda, RastislavThery, Jean ChristopheFaivre, LauraLe Deley, Marie-CecilePaci, AngeloVarga, AndreaGazzah, AnasMassard, ChristophePoinsignon, VianneyMalekzadeh, KattyRibrag, VincentAngevin, EricPostel-Vinay, SophieGomez-Roca, Carlos AlbertoGharib, MyriamDufour, FabienneSoria, Jean-CharlesSpano, Jean-Philippe
- [10] Phase 1 study of safety, pharmacokinetics, and pharmacodynamics of tivantinib in combination with bevacizumab in adult patients with advanced solid tumorsCANCER CHEMOTHERAPY AND PHARMACOLOGY, 2021, 88 (04) : 643 - 654Maguire, William F.Schmitz, John C.Scemama, JonasCzambel, KenLin, YanGreen, Anthony G.Wu, ShaoyuLin, HuangPuhalla, ShannonRhee, JohnStoller, RonaldTawbi, HusseinLee, James J.Wright, John J.Beumer, Jan H.Chu, EdwardAppleman, Leonard J.